#377: Psychedelics — Microdosing, Mind-Enhancing Methods, and More
This episode features a panel that I moderated in front of a standing-room-only crowd at the Milken Institute's Global Conference 2019. It showcases the expertise of researchers, practitioners, and investors on the cutting edge of the use of psychedelics, and it includes a great overview of the science, investing opportunities, anecdotal personal benefits, legal challenges, and much more. I think it’s one of the more comprehensive panels ever done on the subject. Here are the participants: Matthew Johnson — Principal Investigator, Associate Professor, Johns Hopkins Psychedelic Research Unit, Johns Hopkins University School of Medicine Ayelet Waldman — Author, A Really Good Day: How Microdosing Made a Mega Difference in My Mood, My Marriage, and My Life Robin Carhart-Harris — Head of Psychedelic Research, Centre for Psychedelic Research, Department of Brain Sciences, Imperial College London Christian Angermayer — Founder, Apeiron Investment Group and ATAI Life Sciences Please enjoy!